Atai life sciences logo white

ATAI Life Sciences

Private Company

ATAI is a global biotechnology ‘company builder’, seeking to acquire and develop mental health treatments. With tentacles in Berlin, New York and Amsterdam, ATAI has raised large amounts of backing to finance research into psychedelic medicines for depression and other mental illnesses.

ATAI Life Sciences owns a large stake in Compass Pathways, after investing in their Series A round.

Private Company

If ATAI completes a go-public, this page will be updated with stock information and financials.

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.